Study on IDP-001 for Advanced or Metastatic Solid Tumors

Inclusion Criteria

• Be in good overall health with an ECOG performance status of 0 or 1, meaning fully active or restricted in physically strenuous activity but ambulatory.
• Have a confirmed diagnosis of advanced, metastatic, or recurrent solid tumors that cannot be removed by surgery or treated with other approved options.
• Meet specific requirements for previous treatments based on the type of tumor.
• Have at least one measurable tumor that can be tracked using standard criteria.
• Be willing to provide tumor samples for research.
• Have good organ function as determined by blood and other tests.
• Agree to use effective contraception during the study.
• Have a life expectancy of more than 12 weeks.

Exclusion Criteria

• Have significant heart disease or eye disorders.
• Have active and uncontrolled infections like hepatitis B, hepatitis C, or HIV.
• Have serious neurological disorders or need home oxygen.
• Have active autoimmune diseases or skin conditions needing frequent treatment.
• Have had severe allergic reactions to similar treatments.
• Have significant liver disease or uncontrolled diabetes.
• Have bleeding disorders or are participating in another clinical study.
• Be pregnant, breastfeeding, or planning to become pregnant.
• Have allergies to IDP-001 or its ingredients.
• Have unresolved side effects from previous cancer treatments.
• Have had seizures, organ transplants, or certain lung diseases.
• Have had a stroke or mini-stroke before the study.
• Have any other condition that might affect safety or the study's results.